• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Poultry Vaccines Market

    ID: MRFR/Pharma/48780-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    GCC Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Poultry Vaccines Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    GCC Poultry Vaccines Market Summary

    The GCC Poultry Vaccines market is projected to grow from 90 USD Million in 2024 to 150 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Poultry Vaccines Key Trends and Highlights

    • The GCC Poultry Vaccines market is valued at 90 USD Million in 2024.
    • By 2035, the market is expected to reach 150 USD Million, indicating substantial growth.
    • The market is anticipated to experience a compound annual growth rate (CAGR) of 4.75% from 2025 to 2035.
    • Growing adoption of advanced vaccination techniques due to increasing poultry disease outbreaks is a major market driver.

    Market Size & Forecast

    2024 Market Size 90 (USD Million)
    2035 Market Size 150 (USD Million)
    CAGR (2025-2035) 4.75%

    Major Players

    Merial, MSD Animal Health, Zoetis, KPL International, Elanco Animal Health, Phibro Animal Health, Cegelec, Huvepharma, Intervet, Nairobi Pharmaceuticals, Vaxxinova, Boehringer Ingelheim, Alltech, Vetoquinol, Hyline International

    GCC Poultry Vaccines Market Trends

    The GCC poultry vaccines market is experiencing significant trends driven by the rising demand for poultry products and the increasing awareness of animal health. The region has witnessed a surge in poultry production to meet the growing population's food requirements. Governments in GCC countries, recognizing the importance of the poultry sector, are promoting biosecurity measures and vaccination programs to enhance poultry health and productivity. This focus on health and safety is a critical market driver, encouraging farmers to adopt vaccination practices to prevent outbreaks of diseases like avian influenza and Newcastle disease. 

    Furthermore, the need for sustainable farming practices is opening new opportunities within the market.Consumers are becoming more health-conscious and demanding high-quality poultry products, which is pushing producers to adopt advanced vaccination strategies to ensure their livestock's health and minimize disease transmission. This shift toward sustainable practices aligns with the GCC's Vision 2030, where diversifying economies and improving food security are prioritized. Recent trends show an increase in the use of innovative vaccine technologies, such as recombinant vaccines and autogenous vaccines, tailored to combat local pathogens effectively. 

    The collaboration among private companies, universities, and governmental bodies is also on the rise, aiming to develop vaccines that are specific to the regional challenges faced by poultry farmers.As the poultry industry in the GCC continues to evolve, these trends highlight a proactive and forward-thinking approach in the poultry vaccines market, aiming to ensure a stable supply of poultry products while managing health challenges.

    GCC Poultry Vaccines Market Drivers

    Market Segment Insights

    GCC Poultry Vaccines Market Segment Insights

    GCC Poultry Vaccines Market Segment Insights

    Poultry Vaccines Market Type Insights

    Poultry Vaccines Market Type Insights

    The GCC Poultry Vaccines Market is a crucial component in ensuring poultry health, productivity, and food security within the region. Understanding the dynamics of its Type segmentation is essential for grasping the market's overall landscape. The segment encompasses various types of vaccines, which play significant roles in the prevention of diseases affecting poultry. 

    Among these, Live Attenuated Vaccines are particularly noteworthy; they are often favored for their ability to elicit strong immune responses and provide long-lasting immunity. These vaccines, derived from weakened versions of the virus, are effective in controlling infectious diseases, contributing significantly to the health management of poultry in the GCC region, where livestock health is a vital aspect of the economy.

    Inactivated Vaccines, on the other hand, are produced from pathogens that have been killed or inactivated. These vaccines provide a safer alternative and are commonly used in situations where the risk of disease spread is high. Their reliability in preventing outbreaks makes them pivotal in the vaccination strategies employed by poultry producers in the GCC.

    Subunit Vaccines represent another important category in this market segmentation, as they consist of purified pieces of the pathogens, such as proteins, which are effective in inducing immune responses without using live components. This characteristic makes subunit vaccines particularly attractive in the GCC market, where biosecurity and consumer safety are paramount. DNA Vaccines also hold promise in the GCC Poultry Vaccines Market. This innovative type harnesses genetic material to provoke immune responses, offering a cutting-edge approach to disease prevention that is still being explored for its efficacy and potential application within the region's unique agricultural context.

    However, challenges such as vaccine accessibility, storage conditions, and climate factors in this arid region may impact vaccine efficacy and distribution. The future seems favorable amidst trends toward developing advanced vaccine technologies that promise greater effectiveness and safety. These insights concerning Type segmentation highlight the vital role that various vaccine types play in the health of poultry and the overall success of the poultry industry in the GCC. Continued investment in research and development, alongside a commitment to maintaining high biosecurity standards, will further enhance the operational capabilities of this market segment.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Poultry Vaccines Market Species Insights

    Poultry Vaccines Market Species Insights

    The GCC Poultry Vaccines Market has been diversifying and evolving, especially within the Species segment, which comprises Broilers, Layers, Turkeys, and Others. Broilers represent a significant portion of this market, driven by the increasing demand for chicken meat in the GCC region, where poultry consumption continues to rise due to population growth and changing dietary preferences. Layers are also crucial in addressing the region's need for egg production, particularly as consumer preferences shift towards more protein-rich diets. The Turkey segment covers a unique market niche, with demand growing for both culinary and festive occasions.

    Additionally, the 'Others' category includes vaccinations for less common poultry species, contributing to biodiverse poultry farming practices and supporting the region's agricultural sustainability goals. The GCC's commitment to food security and animal health drives robust market growth, with vaccination being a vital component. The market faces challenges such as regulatory developments and disease outbreaks, yet it presents opportunities for innovation in vaccine technology and tailored solutions that could cater to various species needs and improve overall poultry health.

    Poultry Vaccines Market Administration Route Insights

    Poultry Vaccines Market Administration Route Insights

    The Administration Route segment of the GCC Poultry Vaccines Market plays a crucial role in ensuring effective disease prevention and management in poultry. This market segment can be broadly categorized into various methods, including Intramuscular, Subcutaneous, Oral, and Inhalation routes. Intramuscular administration remains widely used due to its efficacy in delivering vaccines directly into the bloodstream, ensuring rapid immune response. Subcutaneous administration is also significant, allowing for slightly less invasive techniques while providing reliable immunity.

    Oral vaccination presents a unique advantage, particularly for delivering vaccines to large flocks, as it simplifies the process and enhances accessibility. Inhalation methods are emerging, capitalizing on the efficiency of respiratory delivery systems to target specific diseases effectively. In the GCC region, advances in these administration techniques align with government initiatives aimed at improving poultry health and production efficiency, ultimately contributing to food security. 

    Furthermore, the growing focus on animal welfare and biosecurity measures is driving innovation within each administration approach, emphasizing a move towards more sophisticated and effective vaccination methods within the poultry industry.

    Poultry Vaccines Market Disease Targeted Insights

    Poultry Vaccines Market Disease Targeted Insights

    The Disease Targeted segment of the GCC Poultry Vaccines Market demonstrates significant potential due to the rising prevalence of poultry diseases in the region. Key diseases like Newcastle Disease and Avian Influenza are critical threats to poultry health and productivity. Newcastle Disease, in particular, remains one of the leading concerns, affecting both the economy and food security in the GCC.

    Infectious Bursal Disease also poses a challenge, as it can lead to decreased immunity in chickens, making them more susceptible to other pathogens.Marek's Disease, which can cause tumors and immunosuppression, is another focus area that emphasizes the need for effective vaccines. 

    The importance of these diseases drives the demand for innovative vaccine solutions, highlighting the opportunity for growth in Research and Development efforts within the GCC Poultry Vaccines Market. The GCC region is actively bolstering its poultry industry as a key component of food security, further underscoring the necessity for robust vaccination strategies to mitigate disease impact and ensure sustainable production.Consequently, the Disease Targeted segment showcases a dynamic landscape characterized by both challenges and opportunities, facilitating advancements in poultry health management.

    Get more detailed insights about GCC Poultry Vaccines Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The GCC Poultry Vaccines Market is an essential segment within the larger veterinary pharmaceuticals industry, catering to a region that has a high demand for poultry products due to significant dietary preferences. The competitive landscape in this market encompasses a variety of local players and international firms, each vying for a share through product differentiation and strategic collaborations. Notably, the increasing awareness about poultry health and biosecurity measures has led to a rise in vaccine adoption, which provides a promising avenue for market players to innovate and expand their offerings.

    To maintain a competitive edge, companies are focusing on developing vaccines that address specific regional diseases, investing in research and development, and leveraging partnerships with local poultry producers to enhance distribution capabilities.

    Merial has established a strong foothold in the GCC Poultry Vaccines Market with its extensive portfolio of products specifically designed to manage poultry health challenges. The company is recognized for its innovative solutions, which have been integral in combating prevalent poultry diseases. Merial's commitment to research has facilitated the development of advanced vaccines that ensure the safety and productivity of poultry operations in the region. Its strategic partnerships with local distributors further bolster its market presence, ensuring that their products are accessible to a wide customer base. 

    The brand is revered for its reliability and effectiveness, which enhances trust among poultry farmers and contributes to its sustained success in the competitive landscape of the GCC.MSD Animal Health also holds a significant position in the GCC Poultry Vaccines Market, offering a comprehensive range of vaccines and health management products tailored to the unique needs of the poultry sector. With its powerful roster of key products, MSD Animal Health stands out for its dedication to advancing poultry health through innovation.

    The company has a robust market presence that is fortified by ongoing investments in research and development, allowing for the introduction of cutting-edge vaccines that tackle various health issues seen in the region's poultry. 

    Notably, their strategic mergers and acquisitions have expanded their capabilities and product offerings within the GCC, enabling them to keep pace with evolving market demands. MSD Animal Health's focus on customer support and education further enhances its reputation, establishing it as a trusted partner for poultry producers seeking effective solutions for disease prevention and management.

    Key Companies in the GCC Poultry Vaccines Market market include

    Industry Developments

    Recent developments in the GCC Poultry Vaccines Market reflect an evolving landscape marked by growing investments and innovations from key players such as Merial, MSD Animal Health, and Zoetis. Current affairs highlight the increased focus on disease prevention in poultry, prompted by outbreaks like avian influenza, leading to higher demand for effective vaccines. In July 2023, Elanco Animal Health announced an expansion of its vaccine portfolio in Saudi Arabia aimed at enhancing poultry health and biosecurity measures.

    Additionally, in August 2023, Boehringer Ingelheim unveiled a partnership with local distributors to improve vaccine accessibility in UAE and Oman markets. Notably, KPL International reported a significant increase in market valuation, driven by rising biosecurity needs and advancements in vaccine technology. Over the past couple of years, major investments in Research and Development by companies like Phibro Animal Health and Vaxxinova have underscored the importance of innovative solutions in tackling poultry diseases. The GCC governments are also actively supporting initiatives that boost the local poultry vaccine manufacturing capabilities to achieve food security and self-sufficiency through enhanced poultry health measures.

    Market Segmentation

    Outlook

    • Newcastle Disease
    • Infectious Bursal Disease
    • Avian Influenza
    • Marek's Disease

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 90.0(USD Million)
    MARKET SIZE 2024 94.0(USD Million)
    MARKET SIZE 2035 150.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.34% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Merial, MSD Animal Health, Zoetis, KPL International, Elanco Animal Health, Phibro Animal Health, Cegelec, Huvepharma, Intervet, Nairobi Pharmaceuticals, Vaxxinova, Boehringer Ingelheim, Alltech, Vetoquinol, Hyline International
    SEGMENTS COVERED Type, Species, Administration Route, Disease Targeted
    KEY MARKET OPPORTUNITIES Increasing poultry production demand, Rising awareness of animal health, Government support for biosecurity measures, Technological advancements in vaccines, Expansion of distribution networks
    KEY MARKET DYNAMICS rising poultry consumption, stringent food safety regulations, increased awareness of animal health, government support for vaccination programs, technological advancements in vaccine development
    COUNTRIES COVERED GCC

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market size of the GCC Poultry Vaccines Market in 2024?

    The GCC Poultry Vaccines Market is expected to be valued at 94.0 million USD in 2024.

    What is the expected market size of the GCC Poultry Vaccines Market by 2035?

    By 2035, the GCC Poultry Vaccines Market is projected to grow to 150.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the GCC Poultry Vaccines Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 4.34% during the period from 2025 to 2035.

    Which segment of the GCC Poultry Vaccines Market holds the largest value in 2024?

    In 2024, the Inactivated Vaccines segment holds the largest value at 40.0 million USD.

    How much is the Live Attenuated Vaccines segment valued at in 2035?

    The Live Attenuated Vaccines segment is expected to be valued at 50.0 million USD by 2035.

    Who are the major players in the GCC Poultry Vaccines Market?

    Key players include Merial, MSD Animal Health, Zoetis, Elanco Animal Health, and Boehringer Ingelheim.

    What is the market size for Subunit Vaccines in 2024?

    The Subunit Vaccines segment is valued at 15.0 million USD in 2024.

    How much is the DNA Vaccines segment projected to grow by 2035?

    The DNA Vaccines segment is anticipated to grow from 9.0 million USD in 2024 to 15.0 million USD by 2035.

    What are some challenges faced by the GCC Poultry Vaccines Market?

    Challenges include maintaining the efficacy of vaccines and rising production costs.

    What opportunities exist in the GCC Poultry Vaccines Market over the forecast period?

    Growing demand for poultry products and advancements in vaccine technology present significant opportunities.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. GCC Poultry Vaccines Market, BY Type (USD Million)
    45. Live Attenuated Vaccines
    46. Inactivated Vaccines
    47. Subunit Vaccines
    48. DNA Vaccines
    49. GCC Poultry Vaccines Market, BY Species (USD Million)
    50. Broilers
    51. Layers
    52. Turkeys
    53. Others
    54. GCC Poultry Vaccines Market, BY Administration Route (USD Million)
    55. Intramuscular
    56. Subcutaneous
    57. Oral
    58. Inhalation
    59. GCC Poultry Vaccines Market, BY Disease Targeted (USD Million)
    60. Newcastle Disease
    61. Infectious Bursal Disease
    62. Avian Influenza
    63. Marek's Disease
    64. Competitive Landscape
    65. Overview
    66. Competitive Analysis
    67. Market share Analysis
    68. Major Growth Strategy in the Poultry Vaccines Market
    69. Competitive Benchmarking
    70. Leading Players in Terms of Number of Developments in the Poultry Vaccines Market
    71. Key developments and growth strategies
    72. New Product Launch/Service Deployment
    73. Merger & Acquisitions
    74. Joint Ventures
    75. Major Players Financial Matrix
    76. Sales and Operating Income
    77. Major Players R&D Expenditure. 2023
    78. Company Profiles
    79. Merial
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. MSD Animal Health
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Zoetis
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. KPL International
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Elanco Animal Health
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Phibro Animal Health
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Cegelec
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Huvepharma
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Intervet
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Nairobi Pharmaceuticals
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Vaxxinova
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Boehringer Ingelheim
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Alltech
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Vetoquinol
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Hyline International
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. References
    170. Related Reports
    171. GCC Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    172. GCC Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY SPECIES, 2019-2035 (USD Billions)
    173. GCC Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
    174. GCC Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY DISEASE TARGETED, 2019-2035 (USD Billions)
    175. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    176. ACQUISITION/PARTNERSHIP
    177. MARKET SYNOPSIS
    178. GCC POULTRY VACCINES MARKET ANALYSIS BY TYPE
    179. GCC POULTRY VACCINES MARKET ANALYSIS BY SPECIES
    180. GCC POULTRY VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
    181. GCC POULTRY VACCINES MARKET ANALYSIS BY DISEASE TARGETED
    182. KEY BUYING CRITERIA OF POULTRY VACCINES MARKET
    183. RESEARCH PROCESS OF MRFR
    184. DRO ANALYSIS OF POULTRY VACCINES MARKET
    185. DRIVERS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    186. RESTRAINTS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    187. SUPPLY / VALUE CHAIN: POULTRY VACCINES MARKET
    188. POULTRY VACCINES MARKET, BY TYPE, 2025 (% SHARE)
    189. POULTRY VACCINES MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    190. POULTRY VACCINES MARKET, BY SPECIES, 2025 (% SHARE)
    191. POULTRY VACCINES MARKET, BY SPECIES, 2019 TO 2035 (USD Billions)
    192. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
    193. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
    194. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2025 (% SHARE)
    195. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2019 TO 2035 (USD Billions)
    196. BENCHMARKING OF MAJOR COMPETITORS

    GCC Poultry Vaccines Market Segmentation

     

     

     

    • Poultry Vaccines Market By Type (USD Million, 2019-2035)

      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • DNA Vaccines

     

    • Poultry Vaccines Market By Species (USD Million, 2019-2035)

      • Broilers
      • Layers
      • Turkeys
      • Others

     

    • Poultry Vaccines Market By Administration Route (USD Million, 2019-2035)

      • Intramuscular
      • Subcutaneous
      • Oral
      • Inhalation

     

    • Poultry Vaccines Market By Disease Targeted (USD Million, 2019-2035)

      • Newcastle Disease
      • Infectious Bursal Disease
      • Avian Influenza
      • Marek's Disease

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027